WallStreetZenWallStreetZen

NYSE: EFX
Equifax Inc Stock

Overview
ForecastEarningsRevenueDividendOwnership
$264.29-4.68 (-1.74%)
Updated Jun 13, 2025
EFX Price
$264.29
Fair Value Price
N/A
Market Cap
$32.82B
52 Week Low
$199.98
52 Week High
$309.63
P/E
53.5x
P/B
6.59x
P/S
5.27x
PEG
1.62x
Dividend Yield
0.44%
Revenue
$5.73B
Earnings
$612.30M
Gross Margin
55.6%
Operating Margin
18.29%
Profit Margin
10.7%
Debt to Equity
1.35
Operating Cash Flow
$1B
Beta
1.11
Next Earnings
Jul 15, 2025
Ex-Dividend
N/A
Next Dividend
N/A

EFX Overview

Equifax Inc. is a consumer credit reporting agencies. Equifax collects and aggregates information on over 800M individual consumers and more than 88M businesses worldwide. In addition to credit and demographic data and services to business, Equifax sells credit monitoring and fraud prevention services directly to consumers. Equifax was founded in 1899 and is headquartered in Atlanta, GA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine EFX's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
A
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Consulting Service

Industry Rating
B
EFX
Ranked#7 of 12

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Huron Consulting Group (HURN)
$134.70B
Forrester Research (FORR)
$10.02B
Cra International (CRAI)
$180.68B
View Top Consulting Service Stocks

Be the first to know about important EFX news, forecast changes, insider trades & much more!

EFX News

Overview

Due Diligence Score

–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EFX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EFX ($264.29) is trading above its intrinsic value of $84.53, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EFX is poor value based on its earnings relative to its share price (53.5x), compared to the US market average (31.36x)
P/E vs Market Valuation
EFX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EFX due diligence checks available for Premium users.

Valuation

EFX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
53.5x
Industry
41.3x
Market
31.36x
EFX is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EFX is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

EFX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
6.59x
Industry
7.74x
EFX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

EFX price to earnings growth (PEG)

For valuing profitable companies with growth potential

EFX is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

EFX's financial health

Profit margin

Revenue
$1.4B
Net Income
$133.1M
Profit Margin
9.2%
EFX's Earnings (EBIT) of $1.05B... subscribe to Premium to read more.
Interest Coverage Financials
EFX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$11.9B
Liabilities
$6.7B
Debt to equity
1.35
EFX's short-term liabilities ($1.73B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EFX's long-term liabilities ($5.01B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EFX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EFX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$223.9M
Investing
-$107.2M
Financing
-$95.8M
EFX's operating cash flow ($1.30B)... subscribe to Premium to read more.
Debt Coverage Financials

EFX vs Consulting Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
EFXC$32.82B-1.74%53.50x6.59x
VRSKC$43.42B-1.11%45.18x353.02x
TRUC$16.38B-2.81%44.43x3.74x
BAHC$12.83B+1.18%14.19x12.79x
FCNC$5.53B-0.66%21.70x2.57x
View Top Consulting Service Stocks

Equifax Stock FAQ

What is Equifax's quote symbol?

(NYSE: EFX) Equifax trades on the NYSE under the ticker symbol EFX. Equifax stock quotes can also be displayed as NYSE: EFX.

If you're new to stock investing, here's how to buy Equifax stock.

What is the 52 week high and low for Equifax (NYSE: EFX)?

(NYSE: EFX) Equifax's 52-week high was $309.63, and its 52-week low was $199.98. It is currently -14.64% from its 52-week high and 32.16% from its 52-week low.

How much is Equifax stock worth today?

(NYSE: EFX) Equifax currently has 124,199,041 outstanding shares. With Equifax stock trading at $264.29 per share, the total value of Equifax stock (market capitalization) is $32.82B.

Equifax stock was originally listed at a price of $35.44 in Dec 31, 1997. If you had invested in Equifax stock at $35.44, your return over the last 27 years would have been 645.74%, for an annualized return of 7.73% (not including any dividends or dividend reinvestments).

How much is Equifax's stock price per share?

(NYSE: EFX) Equifax stock price per share is $264.29 today (as of Jun 13, 2025).

What is Equifax's Market Cap?

(NYSE: EFX) Equifax's market cap is $32.82B, as of Jun 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Equifax's market cap is calculated by multiplying EFX's current stock price of $264.29 by EFX's total outstanding shares of 124,199,041.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.